Melatonin use in managing insomnia in children with autism and other neurogenetic disorders - An assessment by the international pediatric sleep association (IPSA)
Year: 2024
Type: article
Abstract: Though it is widely prescribed for improving sleep of children with autism and other neurogenetic disorders, there is a need for practical guidance to clinicians on the use of melatonin for managing insomnia in this population. Because data were either lacking or inconclusive, a task force was established by the International Pediatric Sleep Association (IPSA) to examine the literature based on clinical trials from 2012 onwards. A summary of evidence pertaining to melatonin's utility and potential side effects, practice-related caveats, and insights for use are published herewith.
Source: Sleep Medicine
Institutions: Mayo Clinic, Vanderbilt University Medical Center, Inserm, Université Paris Cité, NeuroDiderot, Shanghai Jiao Tong University, Shanghai Children's Medical Center, Universidad Nacional de Colombia, Universidad Nacional Autónoma de México, Monash University, Central Queensland University, University of Toronto, Hospital for Sick Children, University of British Columbia, BC Children's Hospital Research Institute, Medical University of Vienna, Sapienza University of Rome, University of Maribor, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Instituto do Cérebro, Pontifícia Universidade Católica do Rio Grande do Sul, University of Southampton
Language: English
Topic: Sleep and related disorders
Subfield: Experimental and Cognitive Psychology
Field: Psychology
Domain: Social Sciences
Open Access status: hybrid
Estimated APC paid: $3,840
OpenAlex ID: W4394987696